AI Tokens
Stock Analysis on Net

Bristol-Myers Squibb Co. (NYSE:BMY)

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Two-Component Disaggregation of ROE

Bristol-Myers Squibb Co., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Sep 30, 2026 39.49% = 10.41% × 3.79
Jun 30, 2026 41.59% = 10.59% × 3.93
Mar 31, 2026 36.25% = 8.41% × 4.31
Dec 31, 2025 38.19% = 7.83% × 4.87
Sep 30, 2025 32.55% = 6.23% × 5.22
Jun 30, 2025 28.96% = 5.33% × 5.43
Mar 31, 2025 31.16% = 5.86% × 5.32
Dec 31, 2024 -54.78% = -9.66% × 5.67
Sep 30, 2024 -42.34% = -7.75% × 5.46
Jun 30, 2024 -38.44% = -6.91% × 5.56
Mar 31, 2024 -37.28% = -6.21% × 6.01
Dec 31, 2023 27.27% = 8.43% × 3.23
Sep 30, 2023 28.57% = 9.08% × 3.15
Jun 30, 2023 24.91% = 8.52% × 2.92
Mar 31, 2023 22.97% = 7.75% × 2.96
Dec 31, 2022 20.37% = 6.53% × 3.12
Sep 30, 2022 20.44% = 6.80% × 3.01
Jun 30, 2022 20.30% = 6.59% × 3.08
Mar 31, 2022 19.79% = 6.07% × 3.26

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The analysis of the two-component DuPont disaggregation reveals a period of relative stability followed by a significant financial shock in 2024 and a subsequent recovery through 2026. The interaction between asset profitability and capital structure highlights a volatile period where increased leverage amplified both losses and subsequent gains.

Return on Assets (ROA)
Operational profitability exhibited a steady increase from March 2022 (6.07%) through September 2023, peaking at 9.08%. This trend reversed sharply in the first quarter of 2024, with ROA turning negative and reaching a trough of -9.66% by December 31, 2024. A recovery began in March 2025 (5.86%), with a consistent upward trajectory observed through September 2026, where ROA reached 10.41%.
Financial Leverage
The leverage ratio remained stable between 2.92 and 3.26 from early 2022 through late 2023. However, a substantial spike occurred in March 2024, with the ratio jumping to 6.01, representing a near-doubling of the previous leverage levels. Following this peak, a gradual deleveraging process is observed, with the ratio steadily declining to 3.79 by September 2026.
Return on Equity (ROE)
ROE fluctuations were heavily influenced by the volatility in both ROA and financial leverage. During the initial stable period, ROE grew from 19.79% to 27.27%. The combination of negative ROA and peak financial leverage in 2024 led to a severe contraction, with ROE falling to -54.78% by year-end. The recovery phase starting in 2025 shows a strong rebound, with ROE climbing to a peak of 41.59% in June 2026, driven primarily by the recovery in asset profitability despite the overall reduction in leverage.

Overall, the results indicate that the negative performance in 2024 was exacerbated by a significant increase in financial leverage. The subsequent recovery is characterized by a return to positive asset returns and a strategic reduction in leverage, ultimately resulting in shareholder returns that exceed pre-2024 levels.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Three-Component Disaggregation of ROE

Bristol-Myers Squibb Co., decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Sep 30, 2026 39.49% = 18.47% × 0.56 × 3.79
Jun 30, 2026 41.59% = 18.87% × 0.56 × 3.93
Mar 31, 2026 36.25% = 15.01% × 0.56 × 4.31
Dec 31, 2025 38.19% = 14.64% × 0.54 × 4.87
Sep 30, 2025 32.55% = 12.57% × 0.50 × 5.22
Jun 30, 2025 28.96% = 10.58% × 0.50 × 5.43
Mar 31, 2025 31.16% = 11.38% × 0.52 × 5.32
Dec 31, 2024 -54.78% = -18.53% × 0.52 × 5.67
Sep 30, 2024 -42.34% = -15.30% × 0.51 × 5.46
Jun 30, 2024 -38.44% = -14.06% × 0.49 × 5.56
Mar 31, 2024 -37.28% = -13.50% × 0.46 × 6.01
Dec 31, 2023 27.27% = 17.83% × 0.47 × 3.23
Sep 30, 2023 28.57% = 18.44% × 0.49 × 3.15
Jun 30, 2023 24.91% = 17.62% × 0.48 × 2.92
Mar 31, 2023 22.97% = 15.95% × 0.49 × 2.96
Dec 31, 2022 20.37% = 13.71% × 0.48 × 3.12
Sep 30, 2022 20.44% = 14.29% × 0.48 × 3.01
Jun 30, 2022 20.30% = 14.04% × 0.47 × 3.08
Mar 31, 2022 19.79% = 13.31% × 0.46 × 3.26

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The financial performance over the analyzed period is characterized by three distinct phases: a period of steady growth from 2022 through 2023, a severe contraction and volatility event throughout 2024, and a robust recovery phase extending into late 2026. The Return on Equity (ROE) exhibits extreme fluctuations, driven primarily by volatility in net profit margins and significant shifts in financial leverage.

Net Profit Margin
Profitability demonstrated a consistent upward trajectory from March 2022 (13.31%) through September 2023 (18.44%). This stability was interrupted in 2024 by a sharp reversal, with margins collapsing into negative territory, reaching a nadir of -18.53% by December 2024. A decisive recovery began in early 2025, with margins returning to positive levels (11.38% in March 2025) and expanding steadily to reach 18.47% by September 2026, surpassing pre-crisis peaks.
Asset Turnover
Asset efficiency remained the most stable component of the DuPont analysis. A gradual and consistent improvement is observed, with the ratio rising from 0.46 in March 2022 to 0.56 by June 2026. This incremental growth suggests a steady improvement in the company's ability to generate revenue from its asset base, regardless of the volatility experienced in profitability and leverage.
Financial Leverage
The leverage ratio remained relatively constant between 2.92 and 3.26 from early 2022 through late 2023. A significant spike occurred in March 2024, where leverage jumped to 6.01, likely reflecting a combination of increased debt or a reduction in equity resulting from the concurrent period of negative net income. Following this peak, a gradual deleveraging trend is observed, with the ratio descending to 3.79 by September 2026.
Return on Equity (ROE) Synthesis
The ROE reflects the combined impact of the three components, showing a climb from 19.79% in March 2022 to 27.27% by December 2023. The collapse in profit margins during 2024, compounded by the surge in financial leverage, resulted in a deep plunge of ROE, reaching -54.78% in December 2024. The subsequent recovery was aggressive; as profit margins returned to positive territory and asset turnover continued to improve, ROE surged to a peak of 41.59% in June 2026, ending the period at 39.49%.

Overall, the data indicates that while asset utilization improved linearly, the company's bottom-line performance and capital structure underwent significant stress in 2024. The post-2024 recovery is marked by a restoration of profitability and a disciplined reduction in leverage, resulting in a higher terminal ROE than was observed in the 2022-2023 period.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Two-Component Disaggregation of ROA

Bristol-Myers Squibb Co., decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Sep 30, 2026 10.41% = 18.47% × 0.56
Jun 30, 2026 10.59% = 18.87% × 0.56
Mar 31, 2026 8.41% = 15.01% × 0.56
Dec 31, 2025 7.83% = 14.64% × 0.54
Sep 30, 2025 6.23% = 12.57% × 0.50
Jun 30, 2025 5.33% = 10.58% × 0.50
Mar 31, 2025 5.86% = 11.38% × 0.52
Dec 31, 2024 -9.66% = -18.53% × 0.52
Sep 30, 2024 -7.75% = -15.30% × 0.51
Jun 30, 2024 -6.91% = -14.06% × 0.49
Mar 31, 2024 -6.21% = -13.50% × 0.46
Dec 31, 2023 8.43% = 17.83% × 0.47
Sep 30, 2023 9.08% = 18.44% × 0.49
Jun 30, 2023 8.52% = 17.62% × 0.48
Mar 31, 2023 7.75% = 15.95% × 0.49
Dec 31, 2022 6.53% = 13.71% × 0.48
Sep 30, 2022 6.80% = 14.29% × 0.48
Jun 30, 2022 6.59% = 14.04% × 0.47
Mar 31, 2022 6.07% = 13.31% × 0.46

Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31).


The Return on Assets (ROA) exhibits a volatile trajectory characterized by a period of steady growth, a significant contraction into negative territory during 2024, and a subsequent recovery through 2026. The overall trend indicates that the company's ability to generate earnings from its assets is highly sensitive to profitability swings rather than changes in asset utilization.

Net Profit Margin
Profitability demonstrated a positive trend throughout 2022 and 2023, peaking at 18.44% in September 2023. This was followed by a severe downturn in 2024, where margins collapsed to -13.50% in March and reached a trough of -18.53% by December. A recovery began in the first quarter of 2025, with margins returning to positive territory and steadily climbing to 18.47% by September 2026, effectively recovering to previous peak levels.
Asset Turnover
Asset efficiency remained relatively stable with a gradual long-term upward trend. The ratio moved from 0.46 in early 2022 to 0.56 by late 2026. Notably, asset turnover did not mirror the volatility of the profit margin; it remained resilient and even improved slightly during the 2024 downturn, suggesting that the operational use of assets remained consistent despite the collapse in net income.
ROA Drivers and Interaction
The disaggregation of ROA reveals that the net profit margin is the primary driver of performance volatility. The sharp decline of ROA to -9.66% in December 2024 was exclusively attributable to the negative net profit margin, as asset turnover remained positive and stable. The recovery of ROA to 10.41% by September 2026 was supported by the restoration of profit margins and a marginal improvement in asset turnover, which provided a slight compounding effect on the overall return.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?